Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1636336
PUBLISHER: IMARC | PRODUCT CODE: 1636336
Fabry Disease Market Report by Type (Type 1, Type 2, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2025-2033
PUBLISHED:
PAGES: 130 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global fabry disease market size reached USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.02% during 2025-2033. The increasing number of patients suffering from fabry disease and the escalating need for effective novel therapies, such as genetic and enzyme replacement therapy, represent some of the key factors driving the market.
Fabry disease, or alpha galactosidase-A deficiency, represents a severe x-linked lysosomal inherited disorder that is caused by the lack of enzymes that are required to metabolize various lipid storage and fat-like components, including oils, fatty acids, and waxes. If left undiagnosed or untreated, it might result in clogging of blood vessels and tissue, progressive kidney failures, nerve damage, and even strokes. Currently, fabry disease can be treated with the support of enzyme replacement therapies (ERT) and adjunct therapy. Apart from this, it can be further diagnosed through genetic, blood, and parenteral examinations to inhibit the occurrence of kidney and heart problems. These approaches prevent the risk of developing first and second-level complications and correct underlying enzyme deficiency. Consequently, hospitals and specialty clinics widely utilize various procedures for the timely diagnosis and effective treatment of the Fabry disease.
Fabry Disease Market Trends:
The increasing number of patients suffering from fabry disease and the escalating need for precise and effective therapies, such as genetic, enzyme replacement substrate reduction, and chaperone treatments to stabilize individuals from suffering disease, are primarily driving the market growth. In line with this, the rising demand for orally administered medications and capsule for disease treatment is acting as another growth-inducing factor. Additionally, the favorable initiatives being undertaken by regulatory bodies to invest in the healthcare sector for the designing of breakthrough disease treatment options are supporting the market growth. Moreover, significant technological advancements, such as the introduction of telemedicine solutions and home care settings for the diagnosis and treatment of Fabry disease, are favoring the market growth. The market is also significantly driven by the rising awareness regarding the disease. There is an increasing consciousness regarding the availability of early-stage diagnosis and multiple preventive measures amongst physicians and individuals, which is contributing to the market growth. The steadily increasing geriatric population, which is susceptible to any kind of chronic ailments, is another factor contributing to the market growth. Other factors, such as significant improvements in the healthcare infrastructure, an enhanced focus on the advancement of the genetic disease therapies, and continuous research and development (R&D) activities to expand treatment and medication portfolios, are creating a positive outlook for the market.
Key Market Segmentation:
Type Insights:
- Type 1
- Type 2
- Others
- The report has also provided a detailed breakup and analysis of the fabry disease market based on the type. This includes Type 1, Type 2 and others.
Diagnosis and Treatment Insights:
- Diagnosis
- Blood Test
- Genetic Test
- Parenteral Test
- Others
- Treatment
- Enzyme Replacement Therapy
- Oral Therapy
- Adjunct Therapy
- Others
End User Insights:
- Hospitals
- Homecare
- Specialty Clinics
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
- The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for Fabry disease. Some of the factors driving the North America fabry disease market included the increasing prevalence of fabry disease and the ongoing approvals of advanced therapeutics by regional governments for the disorder treatment.
Competitive Landscape:
- The report has also provided a comprehensive analysis of the competitive landscape in the global fabry disease market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amicus Therapeutics, Freeline, Idorsia Pharmaceuticals Ltd, JCR Pharmaceuticals Co. Ltd, Protalix BioTherapeutics, Sangamo Therapeutics Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global fabry disease market performed so far and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global fabry disease market?
- What are the key regional markets?
- Which countries represent the most attractive fabry disease markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the diagnosis and treatment?
- What is the breakup of the market based on the end user?
- What is the competitive structure of the global fabry disease market?
- Who are the key players/companies in the global fabry disease market?
Product Code: SR112025A6668
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Fabry Disease Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Type 1
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Type 2
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Diagnosis & Treatment
- 7.1 Diagnosis
- 7.1.1 Market Trends
- 7.1.2 Key Segments
- 7.1.2.1 Blood Test
- 7.1.2.2 Genetic Test
- 7.1.2.3 Parenteral Test
- 7.1.2.4 Others
- 7.1.3 Market Forecast
- 7.2 Treatment
- 7.2.1 Market Trends
- 7.2.2 Key Segments
- 7.2.2.1 Enzyme Replacement Therapy
- 7.2.2.2 Oral Therapy
- 7.2.2.3 Adjunct Therapy
- 7.2.2.4 Others
- 7.2.3 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Homecare
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Specialty Clinics
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
- 10.1 Overview
- 10.2 Drivers
- 10.3 Restraints
- 10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Amicus Therapeutics
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Freeline
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Idorsia Pharmaceuticals Ltd
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.4 JCR Pharmaceuticals Co. Ltd
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Protalix BioTherapeutics
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Sangamo Therapeutics Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.1 Amicus Therapeutics
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Product Code: SR112025A6668
List of Figures
- Figure 1: Global: Fabry Disease Market: Major Drivers and Challenges
- Figure 2: Global: Fabry Disease Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Fabry Disease Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Fabry Disease Market: Breakup by Type (in %), 2024
- Figure 5: Global: Fabry Disease Market: Breakup by Diagnosis & Treatment (in %), 2024
- Figure 6: Global: Fabry Disease Market: Breakup by End User (in %), 2024
- Figure 7: Global: Fabry Disease Market: Breakup by Region (in %), 2024
- Figure 8: Global: Fabry Disease (Type 1) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Fabry Disease (Type 1) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Fabry Disease (Type 2) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Fabry Disease (Type 2) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Fabry Disease (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Fabry Disease (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Fabry Disease (Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Fabry Disease (Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Fabry Disease (Treatment) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Fabry Disease (Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Fabry Disease (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Fabry Disease (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Fabry Disease (Homecare) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Fabry Disease (Homecare) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Fabry Disease (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Fabry Disease (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Fabry Disease (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Fabry Disease (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: North America: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: North America: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: United States: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: United States: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: Canada: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: Canada: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: Asia-Pacific: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: Asia-Pacific: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: China: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: China: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: Japan: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: Japan: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: India: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: India: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: South Korea: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: South Korea: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: Australia: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: Australia: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: Indonesia: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: Indonesia: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: Others: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: Others: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: Europe: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: Europe: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: Germany: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: Germany: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: France: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: France: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: United Kingdom: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: United Kingdom: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: Italy: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: Italy: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: Spain: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: Spain: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: Russia: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: Russia: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Others: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Others: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Latin America: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Latin America: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Brazil: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Brazil: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Mexico: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Mexico: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Others: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: Others: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Middle East and Africa: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Middle East and Africa: Fabry Disease Market: Breakup by Country (in %), 2024
- Figure 74: Middle East and Africa: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 75: Global: Fabry Disease Industry: Drivers, Restraints, and Opportunities
- Figure 76: Global: Fabry Disease Industry: Value Chain Analysis
- Figure 77: Global: Fabry Disease Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Fabry Disease Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Fabry Disease Market Forecast: Breakup by Type (in Million USD), 2025-2033
- Table 3: Global: Fabry Disease Market Forecast: Breakup by Diagnosis & Treatment (in Million USD), 2025-2033
- Table 4: Global: Fabry Disease Market Forecast: Breakup by End User (in Million USD), 2025-2033
- Table 5: Global: Fabry Disease Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Fabry Disease Market: Competitive Structure
- Table 7: Global: Fabry Disease Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.